Member Info for Laura2022

Thankyou Iano

32p would be amazing again

Have you got a link please Trench

For over an hour

Takeovers are becoming so common this year, shows how undervalued the small cap market is

Thanks KingH

I didn't see your first message where you shared the name

Strange that I cannot even buy £500 PYC ßhares at the moment ?

Pursued simultaneously to build out this new capability and a further update will be provided to the market towards the end of the current financial year. We anticipate that, if successful, this new service line could make a material contribution to the Company's revenues and bottom line in the financial year ending 30 June 2025.

Biostatistics update due this week

Morning Stephen

They will only allow 150k shares to be bought...

Wow....amazing story Hopist

Thanks Hopist

Apparently PYC did 1000% in 2 days is that true ?

I know PYC did 200%+ last summer

Hopist /NK

I've only learnt some basics about charts and valuations so please help me if I'm wrong

Chart: something called RSI is qlmost below 0 which seems very low

Value : PYC have won £950,000 of contracts in this year and £500,000qlrradt booked for July 2024 and whole value of business only the same as these combined....that is not fair value

SAE shows how quickly things can change if underlying business is flourishing like PYC has been (multiple contracts)

pyc is only £1.6mln market cap NK

PYC have

1 produced a record H1 and cut losses

2 delivered nearly £1mln in signed orders since June

3 re engaged with DoseMeRx

4 gone from an undisclosed pipliene to £1mln to £1.5mln and...one assumes.. still growing

5 Continued to diversify clients

6 last 3 contracts the incrementally largest in their history

7 new CEO who has helped a multi $$ bio tech NASDAQ

As an aside I got a reply today from PS apologising for late reply to an email 4 weeks ago, he apologised and said it has been a very busy time with the business and will doing end of year accounts for year end.

The company hopes to do a wider communication shorty and thanked forbade continued support

Getech's corporate strategy is a response to these strong underlying trends and focuses on monetising the Company's capabilities across the geo-energy sector as well as seeking opportunities for transformational growth in critical minerals and potentially geological hydrogen. We are working on resolving our near-term liquidity concerns while at the same time evolving our offerings and unique propositions; growing our order book; expanding our pipeline; innovating our business models; and despite some near-term uncertainty over the route through to working capital self-sufficiency, we see exciting strategic prospects for the business.

Michael Covington

Chairman

Be good to see how the AGM goes and wherever KC turns up

May be of interest as to the wider precision therapy market

https://www.londonstockexchange.com/news-article/SYNC/syncona-adds-two-oncology-companies-to-portfolio/16528263

He was so rude at the Q and A re : val201

Good riddance to bad people

Over the last 3mths I have emailed 5 different companies

Peter has responded x 2 to earlier emails but not to the last one

1 BOD responds everything within 48hrs

2 3 others have never responded

Sienna

The A.I predicted tool is now going to be used with DoseMeRx, this post below is courtesy of KingH

DoseseMx is integrated into some of the biggest systems and platforms on earth !!!

DoseMe already integrated to

ILUN HEALTH- MERCK £207 Billion MC

Wolters Kluwer £24 Billion MC

Cerner £26.71 Billion MC

This study Sienna was based in Germany and almost certainly won't be PYC however shows the capability of predictive tools

Correctly predicted

The researchers, led by scientists at University College London and University Medical Center Goettingen, in Germany, took blood samples from a group of people with Parkinson's and another without, to identify eight major proteins most likely to predict who would develop the condition.

They then tested blood from 72 patients at risk of brain disorders such as Parkinson's for those eight protein markers - and followed them up over 10 years.

Using the AI tool, they correctly predicted 16 would develop Parkinson’s - up to seven years before symptoms began.

In total, the test predicted 79% would develop the disease - and the researchers are still following up other patients to confirm its accuracy.